Influence of rivaroxaban compared to vitamin K antagonist treatment upon development of cardiovascular calcification in patients with atrial fibrillation and/or pulmonary embolism
- DOI
- 10.1002/clc.23819
- Published
- 2022-03-25
- Container
- Clinical Cardiology
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/clc.23819,
title = {Influence of rivaroxaban compared to vitamin K antagonist treatment upon development of cardiovascular calcification in patients with atrial fibrillation and/or pulmonary embolism},
author = {Robert Stöhr and Timm Dirrichs and Kinan Kneizeh and Sebastian Reinartz and Dario Frank and Johannes Brachmann and Joerg Schroeder and Leon Schurgers and Claudia Göttsch and Andras Keszei and Jürgen Floege and Nikolaus Marx and Vincent Brandenburg and Alexander Schuh},
year = {2022},
journal = {Clinical Cardiology},
doi = {10.1002/clc.23819},
url = {https://doi.org/10.1002/clc.23819}
}RIS
TY - JOUR TI - Influence of rivaroxaban compared to vitamin K antagonist treatment upon development of cardiovascular calcification in patients with atrial fibrillation and/or pulmonary embolism AU - Robert Stöhr AU - Timm Dirrichs AU - Kinan Kneizeh AU - Sebastian Reinartz AU - Dario Frank AU - Johannes Brachmann AU - Joerg Schroeder AU - Leon Schurgers AU - Claudia Göttsch AU - Andras Keszei AU - Jürgen Floege AU - Nikolaus Marx AU - Vincent Brandenburg AU - Alexander Schuh PY - 2022 JO - Clinical Cardiology DO - 10.1002/clc.23819 UR - https://doi.org/10.1002/clc.23819 ER -
APA
Stöhr, R., Dirrichs, T., Kneizeh, K., Reinartz, S., Frank, D., Brachmann, J., Schroeder, J., Schurgers, L., Göttsch, C., Keszei, A., Floege, J., Marx, N., Brandenburg, V., & Schuh, A. (2022). Influence of rivaroxaban compared to vitamin K antagonist treatment upon development of cardiovascular calcification in patients with atrial fibrillation and/or pulmonary embolism. Clinical Cardiology. https://doi.org/10.1002/clc.23819
Source records
- crossref · retrieved 2026-09-26T23:29:53.771Z